Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...

In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

Developing new topical drugs or cosmetics requires a long, expensive research and marketing process, with each launch ...

Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

Ortho Clinical Diagnostics is hoping to pay down a large portion of its debts by riding a wave of COVID-19 and broader in vitro lab testing demands to a $1.5 billion IPO. The company is offering 70 ...

Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia ...

Information regarding efficient pollen viability testing methods and the most favourable pollen storage conditions for internationally important date palm cultivars is limited. No such information has ...

Although several countries—and even some U.S. states—are beginning to create laws that ban or limit the practice of animal testing for cosmetics, the sad reality is that some companies continue to ...